POSTER SESSION III
Tuesday, March 27, 2007 — 9:30 AM - 12:00 Noon
Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
BREAST PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
1
Assessment of Histologic Features and Biomarkers of Breast Carcinoma Associated with Pathologic Complete Response to Neoadjuvant Chemotherapy
(124)
X Gao, Q Khan, M Davis, C Connor, OW Tawfik, PA Thomas, F Fan - KU Medical Center, KC, KS
Subtypes of Invasive Breast Carcinoma and Pathologic Response to Neoadjuvant Chemotherapy
(182)
G Peiró, FI Aranda, E Adrover, M Planelles, C Alenda, A Payá, J Seguí - Hospital General Universitari, Alacant, Spain
Expression of Prognostic Markers in Core Needle Biopsy and Surgical Specimens in Patients with Breast Carcinoma in Neoadjuvant Chemotherapy
(85)
FI Aranda, G Peiró, E Adrover, M Niveiro, C Alenda, J Seguí, J Sánchez-Payá - Hospital General Iniversitari, Alacant, Spain
Histologic Changes in Breast Carcinoma after Neo-Adjuvant Chemotherapy Correlate with Pathologic Response
(212)
PS Sullivan, SK Apple - UCLA Medical Center, Los Angeles, CA
Overexpression of Cyclin D1 Predicts Poor Response to Neoadjuvant Chemotherapy in T2-T4 Breast Cancer Patients
(202)
RS Saad, KL Denning, M Valenzu, T Julian, YL Liu, JF Silverman - Allegheny General Hospital, Pittsburgh, PA
Decreased Estrogen Receptor and Progesterone Receptor Expression Associated with Neoadjuvant Therapy of Exemestane in Combination with Celecoxib in Postmenopausal Women with Breast Cancer
(108)
JR deHart, RE Jimenez, CL Shapiro, SP Povoski - The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Comprehensive Cancer Center of the Ohio State University, Columbus, OH
Effect of Preoperative Chemotherapy on Locally Advanced Breast Cancer among Mexican Women
(82)
I Alvarado-Cabrero, M Patiño, A Hernandez, S Barroso, E Ruiz - Mexican Oncology Hospital, Mexico, DF, Mexico
LCIS Is Often Composed of Multiple Distinct Subclones Despite Its Monomorphic Appearance: Evidence for Clonal Divergence
(149)
R Kanhere, NS Goldstein - William Beaumont Hospital, Royal Oak, MI
Conserved Patterns of Copy Number Aberrations Detected with Array Comparative Genomic Hybridization Characterize & Distinguish In Situ Lobular & In Situ Ductal Carcinoma
(168)
C Mies, M Guttman, K Dudycz-Sulicz, D Baldwin, G Grant - University of Pennsylvania, Philadelphia, PA
Expression of ERa and ERb in Lobular Carcinoma In Situ
(167)
LP Middleton, GH Perkins, SL Tucker, AA Sahin, SE Singletary - UT MD Anderson Cancer Center, Houston, TX
Lobular Carcinoma In Situ of the Breast and Breast Imaging; a 10-Year Institutional Review
(94)
SK Bihlmeyer, DL Weaver - University of Vermont, Burlington, VT
A Newly Proposed Semi-Automated Method of Grading Invasive Lobular Carcinoma. A Unifying Concept and Correlation with Prognostic Markers and Patient Survival
(222)
X Wang, BF Kimler, MK Davis, F Fan, P Thomas, O Tawfik - Kansas University Medical Center, Kansas City, KS
Clinicopathological Characteristics of the Triad of Tubular Carcinoma, Columnar Cell Lesions and Lobular Carcinoma In Situ
(231)
GQ Young, SM Brandt, SA Hoda - New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
Tubular Carcinoma and Grade 1 (Well Differentiated) Invasive Ductal Carcinoma: Comparison of Associated Flat Epithelial Atypia and Other Intra-Epithelial Lesions
(156)
LP Kunju, CG Kleer - University of Michigan, Ann Arbor, MI
Ductal Carcinoma In Situ with Regressive Changes: Recognition, Immunoprofile and Biologic Behavior
(110)
AB Domfeh, M Chivukula, G Carter, D Dabbs - Magee Womens Hospital, UPMC, Pittsburgh, PA
Breast Conservative Treatment for Ductal Carcinoma in Situ: Correlation of Recurrences with Pathologic Parameters and University of Southern California/Van Nuys Prognostic Index (USC/VNPI)
(89)
M Bansal, V Narra, D Maldonado, A Kapke, U Raju - Henry Ford Hospital, Detroit, MI
Comparative Study of the Profile of Primary DCIS and Subsequent In Situ or Invasive Recurrence
(177)
S Nofech-Mozes, J Spayne, E Rakovitch, L Lickley, HJ Kahn, W Hanna - Sunnybrook Health Sciences Centre, Toronto, ON, Canada
Loss of Expression of Androgen Receptor May Play a Critical Role in the Transformation from In Situ to Invasive Ductal Carcinoma of the Breast
(136)
K Hanley, J Wang, P Bourne, Q Yang, P Tang - Univ. of Rochester Medical Center, Rochester, NY; RTI Health Solutions, Rsearch Triangle Park, NC
Histopathologic Evaluation of Small Node-Negative (T1a,bN0) Invasive Breast Cancer. Prognostic Significance of Associated Ductal Carcinoma In Situ and Fibrocystic Changes
(132)
M Guray, AM Gonzalez-Angulo, EO Hanrahan, K Broglio, V Valero, G Hortobagyi, AA Sahin - UT MD Anderson Cancer Center, Houston, TX
Can High Molecular Weight Cytokeratin, CK-903, Differentiate Benign Proliferative Breast Lesions from Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ?
(86)
M Aziz, S Troob, S Simpson, C Mills, S Bernik - St. Vincent’s Comprehensive Cancer Center, New York, NY
Tumor Type, Nottingham Grade, and Survival Following a Diagnosis of Atypical Ductal Hyperplasia on Initial Breast Biopsy
(205)
ME Sanders, PA Schuyler, JF Simpson, WD Dupont, DL Page - Vanderbilt University Medical Center, Nashville, TN
Magnetic Resonance Image Guided Breast Core Biopsy Findings in High and Low Risk Patients
(138)
M Harshan, D Aslan, M Vazquez - New York Presbyterian Hospital-Weill Cornell, New York, NY
Core Biopsy of the Breast with Atypical Ductal Hyperplasia: Implications for Clinical Management
(230)
K Yao, J Richter, E Doren, J Sinacore, PB Rajan - Loyola University Medical Center, Maywood, IL
Association between Lobular Neoplasia and Columnar-Cell Lesions in Breast Needle Core Biopsies Performed for Calcifications
(166)
SE Mendrinos, BP Wu, CM Carman, SI Fisher, JL Connolly - Sentara Norfolk General Hospital, Norfolk, VA; Breast Care Specialists/Sentara Norfolk General Hospital, Norfolk, VA; Beth Israel Deaconess Medical Center, Boston, MA
button next to any title to add to Itinerary Planner...
Add
